Z. Akgun Et Al. , "Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study," CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.74, no.4, pp.751-756, 2014
Akgun, Z. Et Al. 2014. Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.74, no.4 , 751-756.
Akgun, Z., Saglam, S., YÜCEL, S., Gural, Z., Balik, E., Cipe, G., ... YILDIZ, Ş.(2014). Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study. CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.74, no.4, 751-756.
Akgun, Zuleyha Et Al. "Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study," CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.74, no.4, 751-756, 2014
Akgun, Zuleyha Et Al. "Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.74, no.4, pp.751-756, 2014
Akgun, Z. Et Al. (2014) . "Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study." CANCER CHEMOTHERAPY AND PHARMACOLOGY , vol.74, no.4, pp.751-756.
@article{article, author={Zuleyha Akgun Et Al. }, title={Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study}, journal={CANCER CHEMOTHERAPY AND PHARMACOLOGY}, year=2014, pages={751-756} }